User:Jerrica Flakes/sandbox1
From Proteopedia
(Difference between revisions)
| Line 12: | Line 12: | ||
Going through the whole process, we first start with the Australian Taipan biting a predator, prey, or person. The fangs release the Type II venom and secrete it into the organism’s body, and this frees PLA2 (sPLA2 is “secreted” PLA2). Since it is a taipoxin, it first binds to the nerve terminals and hydrolyzes by binding Ca+2 to the active site ate His-48 and Asp-99. The plasma membrane uses water to take away a proton and breaks the SN2 ester bonds, raising the pH. This reaction will turn the phospholipid into lysophospholipid and fatty acids. When the sPLA2 is attaching to the phospholipid, only a few carbons and amino acids will bind by wrapping around the acyl chain, which has a Ca+2 in the active site/loop. Resulting in an unbalance with developing vesicles for exocytosis. Since the vesicle and the membrane are damaged, it becomes hard for myoglobin and hemoglobin to stay on the extracellular matrix, cut the transport of oxygen to the body, and leading to severe myotoxicity and neurotoxicity. This will lead to the organism experiencing hyperkalemia (the potassium in your blood skyrockets) and myglobinuria (myoglobin dramatically falls and can end up in urine). The peripheral nervous system (every nerve outside the brain and spinal cord) will begin to shut down because the sPLA2 will target the mortar nerve terminal and motor axon terminal and block communication between the cells. Due to sPLA2 binding to the nerves, this will lead to rapid paralysis of the neuromuscular junction meaning the muscles will not begin to work. PLA2 affects and kills the cell and will block communication to muscle cells, which leads to the muscle cells dying. The body will shut down in a matter of thirty minutes after the bite. | Going through the whole process, we first start with the Australian Taipan biting a predator, prey, or person. The fangs release the Type II venom and secrete it into the organism’s body, and this frees PLA2 (sPLA2 is “secreted” PLA2). Since it is a taipoxin, it first binds to the nerve terminals and hydrolyzes by binding Ca+2 to the active site ate His-48 and Asp-99. The plasma membrane uses water to take away a proton and breaks the SN2 ester bonds, raising the pH. This reaction will turn the phospholipid into lysophospholipid and fatty acids. When the sPLA2 is attaching to the phospholipid, only a few carbons and amino acids will bind by wrapping around the acyl chain, which has a Ca+2 in the active site/loop. Resulting in an unbalance with developing vesicles for exocytosis. Since the vesicle and the membrane are damaged, it becomes hard for myoglobin and hemoglobin to stay on the extracellular matrix, cut the transport of oxygen to the body, and leading to severe myotoxicity and neurotoxicity. This will lead to the organism experiencing hyperkalemia (the potassium in your blood skyrockets) and myglobinuria (myoglobin dramatically falls and can end up in urine). The peripheral nervous system (every nerve outside the brain and spinal cord) will begin to shut down because the sPLA2 will target the mortar nerve terminal and motor axon terminal and block communication between the cells. Due to sPLA2 binding to the nerves, this will lead to rapid paralysis of the neuromuscular junction meaning the muscles will not begin to work. PLA2 affects and kills the cell and will block communication to muscle cells, which leads to the muscle cells dying. The body will shut down in a matter of thirty minutes after the bite. | ||
| - | I used these resources for my research and if you want to learn more about Phospholipase A2 and the different mutations, and how they affect the body then are several good references including <ref>DOI:10.1007/s10557-008-6132-9</ref> | + | I used these resources for my research and if you want to learn more about Phospholipase A2 and the different mutations, and how they affect the body then are several good references including <ref>DOI:10.1007/s10557-008-6132-9</ref> <ref>DOI:10.1021/cr200085w</ref> <ref>DOI:10.1016</ref> |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 05:01, 28 April 2021
Phospholipase A2 (maybe something like 'Structure')
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ DOI=10.1016/B978-0-12-416595-3.00001-3
- ↑ Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther. 2009 Feb;23(1):49-59. doi: 10.1007/s10557-008-6132-9. Epub, 2008 Oct 18. PMID:18931897 doi:http://dx.doi.org/10.1007/s10557-008-6132-9
- ↑ Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev. 2011 Oct 12;111(10):6130-85. doi: 10.1021/cr200085w. Epub 2011 Sep 12. PMID:21910409 doi:http://dx.doi.org/10.1021/cr200085w
- ↑ doi: https://dx.doi.org/10.1016
